Base de dados : MEDLINE
Pesquisa : A11.870.740.800.500 [Categoria DeCS]
Referências encontradas : 397 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 40 ir para página                         

  1 / 397 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Registro de Ensaios Clínicos
Texto completo
[PMID]:29244851
[Au] Autor:Leitgeb AM; Charunwatthana P; Rueangveerayut R; Uthaisin C; Silamut K; Chotivanich K; Sila P; Moll K; Lee SJ; Lindgren M; Holmer E; Färnert A; Kiwuwa MS; Kristensen J; Herder C; Tarning J; Wahlgren M; Dondorp AM
[Ad] Endereço:Modus Therapeutics AB, Stockholm, Sweden.
[Ti] Título:Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria.
[So] Source:PLoS One;12(12):e0188754, 2017.
[Is] ISSN:1932-6203
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:SEVERE MALARIA: Even with the best available treatment, the mortality from severe Plasmodium falciparum malaria remains high. Typical features at death are high parasite loads and obstructed micro- vasculature. Infected erythrocytes (IE) containing mature parasites bind to the host receptor heparan sulfate, which is also an important receptor for merozoite invasion. To block merozoite invasion has not previously been proposed as an adjunctive therapeutic approach but it may preclude the early expansion of an infection that else leads to exacerbated sequestration and death. SEVUPARIN IN PHASE I STUDY: The drug sevuparin was developed from heparin because heparan sulfate and heparin are nearly identical, so the rationale was that sevuparin would act as a decoy receptor during malaria infection. A phase I study was performed in healthy male volunteers and sevuparin was found safe and well tolerated. SEVUPARIN IN PHASE I/II CLINICAL STUDY: A phase I/II clinical study was performed in which sevuparin was administered via short intravenous infusions to malaria patients with uncomplicated malaria who were also receiving atovaquone/proguanil treatment. This was a Phase I/II, randomized, open label, active control, parallel assignment study. Sevuparin was safe and well tolerated in the malaria patients. The mean relative numbers of ring-stage IEs decreased after a single sevuparin infusion and mature parasite IEs appeared transiently in the circulation. The effects observed on numbers of merozoites and throphozoites in the circulation, were detected already one hour after the first sevuparin injection. Here we report the development of a candidate drug named sevuparin that both blocks merozoite invasion and transiently de-sequesters IE in humans with P. falciparum malaria. TRIAL REGISTRATION: ClinicalTrials.gov NCT01442168.
[Mh] Termos MeSH primário: Antimaláricos/farmacologia
Atovaquona/farmacologia
Heparina/análogos & derivados
Malária Falciparum/tratamento farmacológico
Merozoítos/efeitos dos fármacos
Parasitemia/tratamento farmacológico
Plasmodium falciparum/efeitos dos fármacos
Proguanil/farmacologia
[Mh] Termos MeSH secundário: Administração Oral
Adolescente
Adulto
Idoso
Antimaláricos/sangue
Antimaláricos/farmacocinética
Área Sob a Curva
Atovaquona/sangue
Atovaquona/farmacocinética
Ligação Competitiva
Esquema de Medicação
Combinação de Medicamentos
Quimioterapia Combinada
Eritrócitos/efeitos dos fármacos
Eritrócitos/parasitologia
Feminino
Heparina/sangue
Heparina/farmacocinética
Heparina/farmacologia
Heparitina Sulfato/química
Heparitina Sulfato/metabolismo
Seres Humanos
Infusões Intravenosas
Malária Falciparum/sangue
Malária Falciparum/parasitologia
Masculino
Merozoítos/fisiologia
Meia-Idade
Carga Parasitária
Parasitemia/sangue
Parasitemia/parasitologia
Plasmodium falciparum/fisiologia
Proguanil/sangue
Proguanil/farmacocinética
Índice de Gravidade de Doença
[Pt] Tipo de publicação:CLINICAL TRIAL, PHASE I; CLINICAL TRIAL, PHASE II; JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Antimalarials); 0 (Drug Combinations); 0 (atovaquone, proguanil drug combination); 0 (sevuparin); 9005-49-6 (Heparin); 9050-30-0 (Heparitin Sulfate); S61K3P7B2V (Proguanil); Y883P1Z2LT (Atovaquone)
[Em] Mês de entrada:1801
[Cu] Atualização por classe:180207
[Lr] Data última revisão:
180207
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171216
[Cl] Clinical Trial:ClinicalTrial
[St] Status:MEDLINE
[do] DOI:10.1371/journal.pone.0188754


  2 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28922424
[Au] Autor:Hopp CS; Bennett BL; Mishra S; Lehmann C; Hanson KK; Lin JW; Rousseau K; Carvalho FA; van der Linden WA; Santos NC; Bogyo M; Khan SM; Heussler V; Sinnis P
[Ad] Endereço:Department of Molecular Microbiology & Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
[Ti] Título:Deletion of the rodent malaria ortholog for falcipain-1 highlights differences between hepatic and blood stage merozoites.
[So] Source:PLoS Pathog;13(9):e1006586, 2017 Sep.
[Is] ISSN:1553-7374
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Proteases have been implicated in a variety of developmental processes during the malaria parasite lifecycle. In particular, invasion and egress of the parasite from the infected hepatocyte and erythrocyte, critically depend on protease activity. Although falcipain-1 was the first cysteine protease to be characterized in P. falciparum, its role in the lifecycle of the parasite has been the subject of some controversy. While an inhibitor of falcipain-1 blocked erythrocyte invasion by merozoites, two independent studies showed that falcipain-1 disruption did not affect growth of blood stage parasites. To shed light on the role of this protease over the entire Plasmodium lifecycle, we disrupted berghepain-1, its ortholog in the rodent parasite P. berghei. We found that this mutant parasite displays a pronounced delay in blood stage infection after inoculation of sporozoites. Experiments designed to pinpoint the defect of berghepain-1 knockout parasites found that it was not due to alterations in gliding motility, hepatocyte invasion or liver stage development and that injection of berghepain-1 knockout merosomes replicated the phenotype of delayed blood stage growth after sporozoite inoculation. We identified an additional role for berghepain-1 in preparing blood stage merozoites for infection of erythrocytes and observed that berghepain-1 knockout parasites exhibit a reticulocyte restriction, suggesting that berghepain-1 activity broadens the erythrocyte repertoire of the parasite. The lack of berghepain-1 expression resulted in a greater reduction in erythrocyte infectivity in hepatocyte-derived merozoites than it did in erythrocyte-derived merozoites. These observations indicate a role for berghepain-1 in processing ligands important for merozoite infectivity and provide evidence supporting the notion that hepatic and erythrocytic merozoites, though structurally similar, are not identical.
[Mh] Termos MeSH primário: Cisteína Endopeptidases/metabolismo
Hepatócitos/metabolismo
Malária/metabolismo
Merozoítos/metabolismo
Plasmodium falciparum/metabolismo
[Mh] Termos MeSH secundário: Animais
Inibidores de Cisteína Proteinase/farmacologia
Eritrócitos/parasitologia
Hepatócitos/parasitologia
Fígado/metabolismo
Malária/parasitologia
Plasmodium falciparum/genética
Proteínas de Protozoários/metabolismo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Cysteine Proteinase Inhibitors); 0 (Protozoan Proteins); EC 3.4.22.- (Cysteine Endopeptidases); EC 3.4.22.- (falcipain)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171017
[Lr] Data última revisão:
171017
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170919
[St] Status:MEDLINE
[do] DOI:10.1371/journal.ppat.1006586


  3 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28834337
[Au] Autor:Chenette EJ
[Ad] Endereço:The FEBS Journal, Editorial Office, Cambridge, UK.
[Ti] Título:Recent buzz in malaria research.
[So] Source:FEBS J;284(16):2556-2559, 2017 Aug.
[Is] ISSN:1742-4658
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:In this Commentary, we highlight the latest findings in three active areas of malaria research: Plasmodium biology; host response; and malaria control, prevention and treatment.
[Mh] Termos MeSH primário: Pesquisa Biomédica
Malária/parasitologia
Malária/transmissão
Plasmodium/fisiologia
[Mh] Termos MeSH secundário: Animais
Pesquisa Biomédica/tendências
Interações Hospedeiro-Parasita
Seres Humanos
Malária/metabolismo
Merozoítos/citologia
Merozoítos/fisiologia
Modelos Biológicos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171002
[Lr] Data última revisão:
171002
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170824
[St] Status:MEDLINE
[do] DOI:10.1111/febs.14160


  4 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28698207
[Au] Autor:Kosaisavee V; Suwanarusk R; Chua ACY; Kyle DE; Malleret B; Zhang R; Imwong M; Imerbsin R; Ubalee R; Sámano-Sánchez H; Yeung BKS; Ong JJY; Lombardini E; Nosten F; Tan KSW; Bifani P; Snounou G; Rénia L; Russell B
[Ad] Endereço:Department of Parasitology and Entomology, Faculty of Public Health, Mahidol University, Bangkok, Thailand.
[Ti] Título:Strict tropism for CD71 /CD234 human reticulocytes limits the zoonotic potential of .
[So] Source:Blood;130(11):1357-1363, 2017 Sep 14.
[Is] ISSN:1528-0020
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Two malaria parasites of Southeast Asian macaques, and , can infect humans experimentally. In Malaysia, where both species are common, zoonotic knowlesi malaria has recently become dominant, and cases are recorded throughout the region. By contrast, to date, only a single case of naturally acquired has been found in humans. In this study, we show that whereas merozoites invade monkey red blood cells indiscriminately in vitro, in humans, they are restricted to reticulocytes expressing both transferrin receptor 1 (Trf1 or CD71) and the Duffy antigen/chemokine receptor (DARC or CD234). This likely contributes to the paucity of detectable zoonotic cynomolgi malaria. We further describe postinvasion morphologic and rheologic alterations in -infected human reticulocytes that are strikingly similar to those observed for These observations stress the value of as a model in the development of blood stage vaccines against vivax malaria.
[Mh] Termos MeSH primário: Antígenos CD/metabolismo
Sistema do Grupo Sanguíneo Duffy/metabolismo
Plasmodium cynomolgi/fisiologia
Receptores de Superfície Celular/metabolismo
Receptores da Transferrina/metabolismo
Reticulócitos/parasitologia
Tropismo
Zoonoses/parasitologia
[Mh] Termos MeSH secundário: Animais
Eritrócitos/parasitologia
Interações Hospedeiro-Parasita
Seres Humanos
Macaca
Merozoítos/fisiologia
Plasmodium vivax/fisiologia
Reologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antigens, CD); 0 (CD71 antigen); 0 (DARC protein, human); 0 (Duffy Blood-Group System); 0 (Receptors, Cell Surface); 0 (Receptors, Transferrin)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171008
[Lr] Data última revisão:
171008
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170713
[St] Status:MEDLINE
[do] DOI:10.1182/blood-2017-02-764787


  5 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28555954
[Au] Autor:Swilks E; Jenkins C; Poynting A; Collins D; Krebs GL
[Ad] Endereço:School of Animal and Veterinary Sciences, Charles Sturt University, Locked Bag 588, Wagga Wagga, New South Wales 2678, Australia.
[Ti] Título:Prevalence and effect of Theileria orientalis infection in homebred calves in the Gloucester region of New South Wales, Australia.
[So] Source:Aust Vet J;95(6):211-216, 2017 Jun.
[Is] ISSN:1751-0813
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: To examine the prevalence of Theileria orientalis in the Gloucester area of New South Wales and its effect on individual animals. METHODS: Blood samples (EDTA and clotted blood) were collected from a total of 55 calves and their dams from 6 properties over a 16-week period. A total of 202 and 190 blood samples were collected from the calves and dams, respectively, and were examined via blood film for the presence of intraerythrocytic T. orientalis piroplasms. Packed cell volume (PCV) was measured to determine infection resulting in anaemia. The presence of antibodies against the T. orientalis major piroplasm surface protein (MPSP) was tested using ELISA. RESULTS: The overall prevalence of T. orientalis infection in both dams and calves from all herds examined was 95%. Mean peak parasitaemia was observed in calves between 6 and 9 weeks of age (P = 0.051), coinciding with a decline in mean PCV. Only 3 (6%) of the blood samples collected from the dams were positive for Theileria-associated antibodies and no significant relationship (P > 0.05) was found between the presence of antibodies in the dams and PCV levels in the calves. There was no evidence that passive transfer of antibodies from dams to calves protected the calves against a decline in PCV. CONCLUSION: This study confirmed a high prevalence of low-level Theileria infection, but low MPSP seroconversion rates, in dams and calves in an area where the disease has been endemic for a number of years.
[Mh] Termos MeSH primário: Doenças dos Bovinos/epidemiologia
Doenças dos Bovinos/parasitologia
Theileriose/epidemiologia
[Mh] Termos MeSH secundário: Anemia/epidemiologia
Anemia/parasitologia
Anemia/veterinária
Animais
Anticorpos Antiprotozoários/sangue
Bovinos
Doenças dos Bovinos/sangue
Ensaio de Imunoadsorção Enzimática/veterinária
Feminino
Masculino
Merozoítos
New South Wales/epidemiologia
Reação em Cadeia da Polimerase/veterinária
Prevalência
Theileria/genética
Theileria/imunologia
Theileriose/sangue
Theileriose/complicações
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibodies, Protozoan)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171006
[Lr] Data última revisão:
171006
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170531
[St] Status:MEDLINE
[do] DOI:10.1111/avj.12593


  6 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28484054
[Au] Autor:Kennedy AT; Wijeyewickrema LC; Huglo A; Lin C; Pike R; Cowman AF; Tham WH
[Ad] Endereço:Infection and Immunity Division, The Walter and Eliza Hall Institute, Parkville, Victoria 3052, Australia.
[Ti] Título:Recruitment of Human C1 Esterase Inhibitor Controls Complement Activation on Blood Stage Merozoites.
[So] Source:J Immunol;198(12):4728-4737, 2017 Jun 15.
[Is] ISSN:1550-6606
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The complement system is a front-line defense system that opsonizes and lyses invading pathogens. To survive, microbes exposed to serum must evade the complement response. To achieve this, many pathogens recruit soluble human complement regulators to their surfaces and hijack their regulatory function for protection from complement activation. C1 esterase inhibitor (C1-INH) is a soluble regulator of complement activation that negatively regulates the classical and lectin pathways of complement to protect human tissue from aberrant activation. In this article, we show that merozoites, the invasive form of blood stage malaria parasites, actively recruit C1-INH to their surfaces when exposed to human serum. We identified MSP3.1, a member of the merozoite surface protein 3 family of merozoite surface proteins, as the direct interaction partner. When bound to the merozoite surface, C1-INH retains its ability to complex with and inhibit C1s, MASP1, and MASP2, the activating proteases of the complement cascade. merozoites that lack MSP3.1 showed a marked reduction in C1-INH recruitment and increased C3b deposition on their surfaces. However, these Δ MSP3.1 merozoites exhibit enhanced invasion of RBCs in the presence of active complement. This study characterizes an immune-evasion strategy used by malaria parasites and highlights the complex relationship between merozoites and the complement system.
[Mh] Termos MeSH primário: Antígenos de Protozoários/metabolismo
Ativação do Complemento
Proteína Inibidora do Complemento C1/metabolismo
Evasão da Resposta Imune
Proteínas de Membrana/metabolismo
Merozoítos/imunologia
Plasmodium falciparum/imunologia
[Mh] Termos MeSH secundário: Antígenos de Protozoários/imunologia
Proteína Inibidora do Complemento C1/genética
Complemento C1s/antagonistas & inibidores
Complemento C1s/imunologia
Complemento C1s/metabolismo
Eritrócitos/parasitologia
Seres Humanos
Serina Proteases Associadas a Proteína de Ligação a Manose/antagonistas & inibidores
Serina Proteases Associadas a Proteína de Ligação a Manose/imunologia
Serina Proteases Associadas a Proteína de Ligação a Manose/metabolismo
Proteínas de Membrana/imunologia
Merozoítos/química
Plasmodium falciparum/crescimento & desenvolvimento
Plasmodium falciparum/metabolismo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antigens, Protozoan); 0 (Complement C1 Inhibitor Protein); 0 (Membrane Proteins); EC 3.4.21.- (MASP1 protein, human); EC 3.4.21.- (MASP2 protein, human); EC 3.4.21.- (Mannose-Binding Protein-Associated Serine Proteases); EC 3.4.21.42 (Complement C1s)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170927
[Lr] Data última revisão:
170927
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170510
[St] Status:MEDLINE
[do] DOI:10.4049/jimmunol.1700067


  7 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28372843
[Au] Autor:Chaney SB; Marsh AE; Lewis S; Carman M; Howe DK; Saville WJ; Reed SM
[Ad] Endereço:Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH, 43210, United States.
[Ti] Título:Sarcocystis neurona manipulation using culture-derived merozoites for bradyzoite and sporocyst production.
[So] Source:Vet Parasitol;238:35-42, 2017 Apr 30.
[Is] ISSN:1873-2550
[Cp] País de publicação:Netherlands
[La] Idioma:eng
[Ab] Resumo:Equine protozoal myeloencephalitis (EPM) remains a significant central nervous system disease of horses in the American continents. Sarcocystis neurona is considered the primary causative agent and its intermediate life stages are carried by a wide host-range including raccoons (Procyon lotor) in North America. S. neurona sarcocysts mature in raccoon skeletal muscle and can produce central nervous system disease in raccoons, mirroring the clinical presentation in horses. The study aimed to develop laboratory tools whereby the life cycle and various life stages of S. neurona could be better studied and manipulated using in vitro and in vivo systems and compare the biology of two independent isolates. This study utilized culture-derived parasites from S. neurona strains derived from a raccoon or from a horse to initiate raccoon infections. Raccoon tissues, including fresh and cryopreserved tissues, were used to establish opossum (Didelphis virginiana) infections, which then shed sporocyts with retained biological activity to cause encephalitis in mice. These results demonstrate that sarcocysts can be generated using in vitro-derived S. neurona merozoites, including an isolate originally derived from a naturally infected horse with clinical EPM. This study indicates the life cycle can be significantly manipulated in the laboratory without affecting subsequent stage development, allowing further purification of strains and artificial maintenance of the life cycle.
[Mh] Termos MeSH primário: Merozoítos/fisiologia
Oocistos/fisiologia
Guaxinins/parasitologia
Sarcocystis/fisiologia
Sarcocistose/veterinária
[Mh] Termos MeSH secundário: Animais
Criopreservação
Camundongos
Músculo Esquelético/parasitologia
Sarcocistose/parasitologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171030
[Lr] Data última revisão:
171030
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170405
[St] Status:MEDLINE


  8 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28361273
[Au] Autor:Gong Z; Yin H; Ma X; Liu B; Han Z; Gou L; Cai J
[Ad] Endereço:State Key Laboratory of Veterinary Etiological Biology; Key Laboratory of Veterinary Parasitology of Gansu Province, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Science, Lanzhou, Gansu Province, 730046, People's Republic of China.
[Ti] Título:Widespread 5-methylcytosine in the genomes of avian Coccidia and other apicomplexan parasites detected by an ELISA-based method.
[So] Source:Parasitol Res;116(5):1573-1579, 2017 May.
[Is] ISSN:1432-1955
[Cp] País de publicação:Germany
[La] Idioma:eng
[Ab] Resumo:To date, little is known about cytosine methylation in the genomic DNA of apicomplexan parasites, although it has been confirmed that this important epigenetic modification exists in many lower eukaryotes, plants, and animals. In the present study, ELISA-based detection demonstrated that low levels of 5-methylcytosine (5-mC) are present in Eimeria spp., Toxoplasma gondii, Cryptosporidium spp., and Neospora caninum. The proportions of 5-mC in genomic DNA were 0.18 ± 0.02% in E tenella sporulated oocysts, 0.19 ± 0.01% in E. tenella second-generation merozoites, 0.22 ± 0.04% in T. gondii tachyzoites, 0.28 ± 0.03% in N. caninum tachyzoites, and 0.06 ± 0.01, 0.11 ± 0.01, and 0.09 ± 0.01% in C. andersoni, C. baileyi, and C. parvum sporulated oocysts, respectively. In addition, we found that the percentages of 5-mC in E. tenella varied considerably at different life stages, with sporozoites having the highest percentage of 5-mC (0.78 ± 0.10%). Similar stage differences in 5-mC were also found in E. maxima, E. necatrix, and E. acervulina, the levels of 5-mC in their sporozoites being 4.3-, 1.8-, 2.5-, and 2.0-fold higher than that of sporulated oocysts, respectively (p < 0.01). Furthermore, a total DNA methyltransferase-like activity was detected in whole cell extracts prepared from E. tenella sporozoites. In conclusion, genomic DNA methylation is present in these apicomplexan parasites and may play a role in the stage conversion of Eimeria.
[Mh] Termos MeSH primário: 5-Metilcitosina/análise
Galinhas/parasitologia
Coccidiose/veterinária
Cryptosporidium/genética
DNA de Protozoário/genética
Eimeria tenella/genética
Neospora/genética
Toxoplasma/genética
[Mh] Termos MeSH secundário: Animais
Coccidiose/parasitologia
Metilação de DNA/genética
Ensaio de Imunoadsorção Enzimática
Merozoítos/citologia
Oocistos/citologia
Esporozoítos/citologia
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (DNA, Protozoan); 6R795CQT4H (5-Methylcytosine)
[Em] Mês de entrada:1707
[Cu] Atualização por classe:171007
[Lr] Data última revisão:
171007
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170401
[St] Status:MEDLINE
[do] DOI:10.1007/s00436-017-5434-x


  9 / 397 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28351409
[Au] Autor:Muh F; Han JH; Nyunt MH; Lee SK; Jeon HY; Ha KS; Park WS; Hong SH; Ahmed MA; Na S; Takashima E; Tsuboi T; Han ET
[Ad] Endereço:Department of Medical Environmental Biology and Tropical Medicine, School of Medicine, Kangwon National University, Chuncheon, Gangwon-do, Republic of Korea.
[Ti] Título:Identification of a novel merozoite surface antigen of Plasmodium vivax, PvMSA180.
[So] Source:Malar J;16(1):133, 2017 Mar 28.
[Is] ISSN:1475-2875
[Cp] País de publicação:England
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Although a number of Plasmodium vivax proteins have been identified, few have been investigated as potential vaccine candidates. This study characterized the Plasmodium vivax merozoite surface antigen 180 (PvMSA180, PVX_094920), a novel P. vivax antigenic protein. METHODS: The target gene was amplified as four overlapping domains (D1, D2, D3 and D4) to enable expression of the recombinant protein using cell-free and bacterial expression systems. The recombinant PvMSA180 proteins were used in protein microarrays to evaluate the humoral immune response of 72 vivax-infected patients and 24 vivax-naïve individuals. Antibodies produced in mice against the PvMSA180-D1 and -D4 domains were used to assess the subcellular localization of schizont-stage parasites with immunofluorescence assays. A total of 51 pvmsa180 sequences from 12 countries (41 sequences from PlasmoDB and 6 generated in this study) were used to determine the genetic diversity and genealogical relationships with DNAsp and NETWORK software packages, respectively. RESULTS: PvMSA180 consists of 1603 amino acids with a predicted molecular mass of 182 kDa, and has a signal peptide at the amino-terminus. A total of 70.8% of patients (51/72) showed a specific antibody response to at least one of the PvMSA180 domains, and 20.8% (15/72) exhibited a robust antibody response to at least three of the domains. These findings suggest that PvMSA180 is targeted by the humoral immune response during natural infection with P. vivax. Immunofluorescence analysis demonstrated that PvMSA180 is localized on the merozoite surface of schizont-stage parasites, and pvmsa180 sequences originating from various geographic regions worldwide showed low genetic diversity. Twenty-two haplotypes were found, and haplotype 6 (Hap_6, 77%) of pvmsa180 was detected in isolates from six countries. CONCLUSIONS: A novel P. vivax surface protein, PvMSA180, was characterized in this study. Most of P. vivax-infected patients had specific antibodies against particular antigenic domains, indicating that this protein is immunogenic in naturally exposed populations. Genetic analysis of worldwide isolates showed that pvmsa180 is less polymorphic than other well-known candidates and that some haplotypes are common to several countries. However, additional studies with a larger sample size are necessary to evaluate the antibody responses in geographically separated populations, and to identify the function of PvMSA180 during parasite invasion.
[Mh] Termos MeSH primário: Antígenos de Protozoários/análise
Antígenos de Superfície/análise
Merozoítos/química
Plasmodium vivax/química
[Mh] Termos MeSH secundário: Adolescente
Adulto
Animais
Anticorpos Antiprotozoários/sangue
Antígenos de Protozoários/química
Antígenos de Protozoários/genética
Antígenos de Protozoários/imunologia
Antígenos de Superfície/química
Antígenos de Superfície/genética
Antígenos de Superfície/imunologia
Feminino
Variação Genética
Seres Humanos
Masculino
Merozoítos/imunologia
Camundongos Endogâmicos BALB C
Microscopia de Fluorescência
Peso Molecular
Filogeografia
Plasmodium vivax/imunologia
Sinais Direcionadores de Proteínas/genética
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibodies, Protozoan); 0 (Antigens, Protozoan); 0 (Antigens, Surface); 0 (Protein Sorting Signals)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170606
[Lr] Data última revisão:
170606
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170330
[St] Status:MEDLINE
[do] DOI:10.1186/s12936-017-1760-9


  10 / 397 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28329101
[Au] Autor:Kana IH; Adu B; Tiendrebeogo RW; Singh SK; Dodoo D; Theisen M
[Ad] Endereço:Department for Congenital Disorders, Statens Serum Institute, Copenhagen, Denmark
[Ti] Título:Naturally Acquired Antibodies Target the Glutamate-Rich Protein on Intact Merozoites and Predict Protection Against Febrile Malaria.
[So] Source:J Infect Dis;215(4):623-630, 2017 02 15.
[Is] ISSN:1537-6613
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Background: Plasmodium species antigens accessible at the time of merozoite release are likely targets of biologically functional antibodies. Methods: Immunoglobulin G (IgG) antibodies against intact merozoites were quantified in the plasma of Ghanaian children from a longitudinal cohort using a novel flow cytometry-based immunofluorescence assay. Functionality of these antibodies, as well as glutamate-rich protein (GLURP)-specific affinity-purified IgG from malaria hyperimmune Liberian adults, was assessed by the opsonic phagocytosis (OP) assay. Results: Opsonic phagocytosis activity was strongly associated (hazard ratio [HR] = 0.46; 95% confidence interval [CI] = .30-.73; P = .0008) with protection against febrile malaria. Of the antimerozoite-specific antibodies, only IgG3 was significantly associated with both OP and protection (HR = 0.53; 95% CI = .34-.84; Pcorrected = .03) against febrile malaria. Similarly, GLURP-specific antibodies previously shown to be protective against febrile malaria in this same cohort were significantly associated with OP activity in this study. GLURP-specific antibodies recognized merozoites and also mediated OP activity. Conclusions: These findings support previous studies that found OP of merozoites to be associated with protection against malaria and further shows IgG3 and GLURP antibodies are key in the OP mechanism, thus giving further impetus for the development of malaria vaccines targeting GLURP.
[Mh] Termos MeSH primário: Anticorpos Antiprotozoários/imunologia
Malária/imunologia
Proteínas de Protozoários/imunologia
[Mh] Termos MeSH secundário: Anticorpos Antiprotozoários/sangue
Antígenos de Protozoários/sangue
Criança
Pré-Escolar
Estudos de Coortes
Febre/imunologia
Seguimentos
Gana
Seres Humanos
Imunoglobulina G/sangue
Imunoglobulina G/imunologia
Lactente
Modelos Logísticos
Estudos Longitudinais
Merozoítos/imunologia
Fagocitose
Plasmodium falciparum/imunologia
Modelos de Riscos Proporcionais
Proteínas de Protozoários/sangue
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibodies, Protozoan); 0 (Antigens, Protozoan); 0 (Immunoglobulin G); 0 (Protozoan Proteins); 145112-81-8 (glutamate-rich protein, Plasmodium)
[Em] Mês de entrada:1705
[Cu] Atualização por classe:170615
[Lr] Data última revisão:
170615
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:170323
[St] Status:MEDLINE
[do] DOI:10.1093/infdis/jiw617



página 1 de 40 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde